Contact details

Naomi Leach

T: +44 20 7809 2960 M: +44 7769 143 367 Email Naomi | vCard Office: London

Awards

Intellectual property: Patents (contentious and non-contentious)

Intellectual property: Patents (contentious and non-contentious)

Commercial contracts, Power (including electricity, nuclear and renewables) and Data protections

Commercial contracts, Power (including electricity, nuclear and renewables) and Data protections

Naomi Leach Partner

Contact details

Naomi Leach

Naomi Leach
Partner

T: +44 20 7809 2960 M: +44 7769 143 367 Email Naomi | vCard Office: London

Naomi has a strong commercial practice, with particular expertise in relation to transactional IP matters. Her practice includes long-term research collaboration and management agreements, licensing arrangements, outsourcing and service agreements, distribution and manufacturing arrangements and data protection. She also frequently works with corporate finance colleagues on the IP/IT and data protection aspects of M&A transactions.
  • Profile
  • Services
  • Sectors

Naomi has significant experience working with clients in IP-rich sectors including life sciences, technology and hotels and leisure. She is also responsible for the firm’s growing digital health practice. In addition Naomi advises on the full range of commercial contracts including long term services agreements, software licensing arrangements and outsourcing agreements and data protection law. Naomi has spent time on secondment with clients of the firm including Accor Hotels.

Naomi’s transactional IP experience includes  advising clients on licensing (including franchise and hotel management arrangements), partnering, collaboration and R&D agreements (particularly for Biotech and Pharmaceutical companies) as well as on the IP aspects of mergers, acquisitions and investments.

Her recent commercial experience includes advising a life sciences client in relation to the outsourcing of its recruitment services in Europe and Asia, the commercial manufacturing agreement for a pharmaceutical product and advising in relation to the branding and management of an Ultra Luxury hotel in London.

Finally, in her data protection practice, Naomi has advised in relation to a number GDPR compliance projects, has worked with various Art Galleries for the purposes of their electronic-marketing practices and has advised in relation to the interaction between GDPR compliance and compliance with the Clinical Trials Regulation.

  • Intellectual property
  • Data protection and information
  • Commercial, outsourcing and technology

Brand licensing arrangements for hotels

Naomi has advised on a number of franchise and hotel management agreements including in particular the brand licensing arrangements. Clients include Accor Hotels, Mandarin Oriental and various hotel owners.

Kymab Limited

Advised Kymab on a number of research collaboration agreements with long term patent and know how licences and options.

BTG

Advised in relation to the out-licensing of its IP portfolio relating to a product for treatment in the field of oncology with upfront payments, milestones and royalties.

Highview Power

Advised in relation to a territorial licence for the exploitation of its Liquid Air Energy Storage technology and related IP.

One of the world’s leading manufacturers of play materials

Advised in relation to a long term collaboration agreement for the use of the brand.

BTG

Advising the life sciences company on its GDPR compliance program and, in particular, advising on the interaction between GDPR compliance and its Informed Consent Requirements under Clinical Trials.

UCB Pharma

Advised in relation to compliance with the UK Human Samples Act, requirements for consent and the interplay with GDPR requirements.

'Big Four' professional services firm

Providing data protection advice to a "Big Four" professional services firm in relation to various SAR compliance requirements and its contractual arrangements and standard terms.

Art galleries 

Naomi presented to a collection of art galleries in relation to their GDPR compliance requirements following which she advised a number of galleries in particular in relation to their ability to market effectively to customers.

Iiko

Advised this POS software platform in relation to their entry into the European market and compliance with GDPR, including contractual terms with the customers and suppliers along with the end-user’s consumer terms.

Schonfeld Strategic Advisors

Providing advice to this UK based hedge fund in relation to its data protection compliance program.

Life sciences company

Advising in relation to the outsourcing of its talent acquisition and recruitment services in Europe and Asia.

Steer Davies Gleave

Advised in relation to the outsourcing of its Cloud storage system and an App Development Agreement.

Arriva Trains

Advised in relation to its Smart Ticketing design, implementation and maintenance project.

More: Commercial, outsourcing and technology

  • Life sciences
  • Technology
  • Hotels and leisure

Multinational pharmaceutical company

Naomi spent 18 months on a part- time secondment to a multinational pharmaceutical company. The scope of work included advising on distribution arrangements, IT licences and data protection, manufacturing and sales agreements.

Kymab

Advised Kymab on a number of research collaboration agreements with long term patent and know how licences and options, including in relation to Kymab’s “Kymouse” technology.

A biochemistry laboratory

Advised in relation to a number of commercial agreements including, in particular, an international Business Process Outsourcing Agreement across Europe and Asia, various software licensing arrangments and advice in relation to the appointment of a Representative for the purposes of compliance with the Clinical Trials Directive.

BTG

Advised in relation to the out-licensing of its IP portfolio relating to a product for treatment in the field of oncology with upfront payments, milestones and royalties.

UCB

Naomi has worked extensively with UCB on a range of agreements including Research Collaboration Agreements, Master Services Agreements, Platform Technology collaborations and in relation to its compliance with Human Samples legislation and GDPR.

International pharma company

Advised in relation to a collaboration with Verily Sciences, the Google Life Sciences company, in relation to the use of Verily’s wearable technology as part of clinical trial programme.

Shield Therapeutics

Advised in relation to the licensing of commercialisation rights in Europe, Australia and New Zealand of Shield’s product Feraccru for the treatment of iron deficiency with upfront fee, and ongoing milestone and royalty payments.

Otsuka

Naomi has worked with Otsuka in relation to the production of a suite of template agreements for use in its business including a Master Services Agreement, Sponsorship Agreement and HCP/HCO arrangements.

More: Life sciences

Steer Davies Gleave

Advised in relation to the outsourcing of its Cloud storage system and an App Development Agreement.

Arriva Trains

Advised in relation to its Smart Ticketing design, implementation and maintenance project.

Funding Circle

Advised FinTech client Funding Circle in relation to a master services agreement and its standard terms and conditions template.

Simply Business

Advised online insurance company in relation to the procurement of software development services.

Iiko

Advised this POS software platform in relation to their entry into the European market and compliance with GDPR, including contractual terms with the customers and suppliers along with the end-user’s consumer terms.

More: Technology

Accor

Advised in relation to its Franchise Agreement structure, in relation to various commercial agreements and on its GDPR compliance requirements. Naomi has also spent time on secondment at Accor Hotels.

Mandarin Oriental

Advised in relation to an Offshore Management Agreement, Onshore Management Agreement and related Residence Property Management Agreement. Naomi has also advised MOHG in relation to the use of Influencer Agreements.

Property Investment Company

Advised in relation to the development and management of an Ultra Luxury Hotel in central London.

Osprey Equity Partners

Advised this real estate and development specialist in relation to a Hotel Management Agreement for an ApartHotel in central London.

More: Hotels and leisure

Awards

Intellectual property: Patents (contentious and non-contentious)

Intellectual property: Patents (contentious and non-contentious)

Commercial contracts, Power (including electricity, nuclear and renewables) and Data protections

Commercial contracts, Power (including electricity, nuclear and renewables) and Data protections

Latest news & insights

20 Nov 2023

From News

Stephenson Harwood advises on $25 million funding in ViaNautis Bio

Stephenson Harwood LLP has advised UCB Ventures, BGF and 4Bio Capital, who led the over-subscribed Series A funding round of $25million in ViaNautis Bio.

More

05 Sep 2023

From News

Stephenson Harwood advises Flarin on fundraise

Law firm Stephenson Harwood LLP has advised Flarin, the joint pain relief brand, on its fundraise through existing investor IW Capital and through ITV's Media for Equi..

More

05 Sep 2023

From News

Success for Stephenson Harwood’s IP team

Members of Stephenson Harwood’s intellectual property (IP) team have been recognised in several leading IP and patent directories, including Managing IP’s ‘IP STARS’, ..

More

15 May 2023

From News

Stephenson Harwood advises Bicycle Therapeutics on radiotherapy deal with Bayer

Law firm Stephenson Harwood LLP has advised Bicycle Therapeutics plc on its recent strategic collaboration agreement with Bayer to discover and develop Bicycle radioco..

More

30 Mar 2023

From News

Stephenson Harwood advises Bicycle Therapeutics on radiopharmaceuticals deal with Novartis

Law firm Stephenson Harwood LLP has advised Bicycle Therapeutics on its recent strategic collaboration agreement with Novartis to discover and develop multiple targete..

More

31 Aug 2022

From Insights

Data Protection update - August 2022

Welcome to our data protection bulletin, covering the key developments in data protection law from August 2022.

More

05 Aug 2022

From Insights

Data Protection update - July 2022

Welcome to our data protection bulletin, covering the key developments in data protection law from July 2022.

More

25 Jul 2022

From News

Stephenson Harwood advises on Miers Construction Products sale

Law firm Stephenson Harwood LLP has advised the sellers of Miers Construction Products Ltd (MCP) on its sale to SIG PLC.

More

12 Jul 2022

From News

Success for Stephenson Harwood's IP partners

Stephenson Harwood partners Alexandra Pygall, Rob Jacob and Naomi Leach have been recognised as legal experts in a range of leading intellectual property publications.

More

07 Jul 2022

From Insights

Data Protection update - June 2022

Welcome to our data protection bulletin, covering the key developments in data protection law from June 2022.

More

01 Jun 2022

From Insights

Data Protection update - May 2022

Welcome to our data protection bulletin, covering the key developments in data protection law from May 2022.

More

05 May 2022

From Insights

Data Protection update - April 2022

Welcome to our data protection bulletin, covering the key developments in data protection law from April 2022.

More

06 Apr 2022

From Insights

Data Protection update - March 2022

Welcome to our data protection bulletin, covering the key developments in data protection law from March 2022.

More

04 Mar 2022

From Insights

Data Protection update - February 2022

Welcome to our data protection bulletin, covering the key developments in data protection law from February 2022.

More

01 Mar 2022

From News

Stephenson Harwood advises Civica on LCSL disposal

Law firm Stephenson Harwood LLP has advised Civica, a private equity backed business, on the sale of its licensing and cloud software lifecycle (LCSL) business to SCC,..

More

14 Feb 2022

From Insights

Life sciences A to Z - D is for data opt-out

The national data opt-out ("NDO") was introduced on 25 May 2018 enabling patients to opt out from the use of their personal data for research or planning purposes.

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.